San Carlos, CA, United States of America

Pina M Cardarelli



Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Pina M Cardarelli: Innovator in Therapeutic Prodrug Compounds

Introduction

Pina M Cardarelli is a notable inventor based in San Carlos, CA (US). She has made significant contributions to the field of therapeutic agents, particularly through her innovative work on prodrug compounds. With a total of 3 patents, her research focuses on enhancing the efficacy of treatments through novel chemical modifications.

Latest Patents

Among her latest patents, Cardarelli has developed CD10-activated prodrug compounds. These compounds are modified forms of therapeutic agents designed to improve treatment outcomes. A typical prodrug compound includes a therapeutic agent, an oligopeptide, a stabilizing group, and, optionally, a linker group. The unique aspect of these prodrugs is that they are cleavable by the CD10 enzyme, which allows for targeted therapeutic action. Additionally, methods of treatment using these prodrugs and strategies for designing them are also disclosed in her patents.

Career Highlights

Pina M Cardarelli has been associated with Medarex Inc., where she has furthered her research and development efforts. Her work has been instrumental in advancing the understanding and application of prodrug technology in medicine.

Collaborations

Throughout her career, Cardarelli has collaborated with esteemed colleagues, including Christopher Robert Bebbington and Matthew H Nieder. These partnerships have contributed to the successful development of her innovative compounds.

Conclusion

Pina M Cardarelli stands out as a pioneering inventor in the realm of therapeutic prodrug compounds. Her contributions continue to influence the field of medicine, showcasing the importance of innovation in developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…